Compare ING Groep NV (ING) vs Novavax Inc (NVAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ING Groep NV vs Novavax Inc — how do they compare? ING Groep NV trades at $32.22 (market cap $92.65B), while Novavax Inc trades at $7.9 (market cap $1.30B). The key difference: ING Groep NV is far larger — about 71.3× Novavax Inc's market cap, and ING Groep NV pays a 3.93% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| ING | NVAX | |
|---|---|---|
Market Cap | $92.65B | $1.30B |
Sector | Financials | Health |
52-Week High | $33.31 | $11.19 |
52-Week Low | $22.71 | $6.22 |
Dividend Yield | 3.93% | — |
Enterprise Value | — | $800.50M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ING Groep NV
The merger of the Dutch postal bank and NN Insurance in 1991 created ING. Through a series of further acquisitions ING build up a global footprint. The 2008 financial crisis forced ING to seek government support--a precondition of which was that ING should separate its banking and insurance activities, which saw ING revert to being solely a bank. ING has market- leading banking operations in the Netherlands and Belgium, and a range of digital banks across Europe and Australia. Its global wholesale banking operation is primarily focused on lending.
Read more on ING →About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →
